InfuSystems Holdings Inc (INFU) achieved a 7.2% revenue growth in 2024, with significant contributions from oncology and pain management sectors. Gross margins increased by 2% year-over-year to 52 ...

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care ...

A large exercise of company stock options by Richard Dilorio, Chief Executive Officer at InfuSystems Holdings INFU was disclosed in a new SEC filing on March 11, as part of an insider exercise.

NYSE:INFU opened at $6.11 on Thursday. The firm has a fifty day simple moving average of $7.92 and a two-hundred day simple moving average of $7.59. InfuSystem has a 12 month low of $5.74 and a 12 ...